Xenon Pharmaceuticals Inc. promoted Ian Mortimer to president in addition to his current role as CFO.
In addition, the company appointed Ernesto Aycardi as chief medical officer, effective March 19.
Aycardi worked from 2014 to 2018 at Teva Pharmaceutical Industries Ltd., where he most recently served as vice president and head of clinical trial operations, biostatistics and data sciences and clinical pharmacology.
Canada-based Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders.
